News
-
Glucojel profits you
Wednesday | Aug 13 2025ALL the money raised by Glucojel assists the Pharmacy Guild of Australia in its advocacy work for community pharmacy - learn more on page four.
-
Pain relief choice
Wednesday | Aug 13 2025NOVA Pharmaceuticals' MediChoice offers rapid release paracetamol in packs of 16 or 32, as well as double-strength ibuprofen 400mg in packs of 30.
-
GPs call for isotretinoin rights
Wednesday | Aug 13 2025THE Royal Australian College of GPs has lodged an application with the TGA to let GPs prescribe isotretinoin for moderate-to-severe acne or treatment-resistant rosacea, Australian Doctor has reported.
-
Lifestyle care needed in mental health
Wednesday | Aug 13 2025MENTAL health experts are calling for an urgent increase in investment for lifestyle interventions to improve care and help close the 15-year life expectancy gap faced by people with mental illness.
-
Leafio launches loyalty program
Wednesday | Aug 13 2025AUSTRALIA'S largest medical cannabis wholesaler, Leafio, has launched a new loyalty hub for registered Leafio pharmacists, featuring a four-tiered program of benefits and rewards.
-
Dispensary Corner 13 Aug 25
Wednesday | Aug 13 2025IN NEWS that surprises no-one, a study from LaTrobe University has revealed that TikTok is responsible for sharing unreliable birth control advice.
-
Mag-Sup powder – a better way to absorb magnesium
Wednesday | Aug 13 2025MAG-SUP powder is a high absorption magnesium supplement for use in magnesium deficiencies.
-
Eurax Cream Crotamiton 100mg/g
Wednesday | Aug 13 2025EURAX Cream provides six to 10 hours of lasting relief for itches from insect bites, allergies, hives and mild sunburn.
-
CWH raises $1.27m for Gotcha4Life
Tuesday | Aug 12 2025CHEMIST Warehouse has raised $1.27 million to support the Gotcha4Life Foundation as part of its 2025 Men's Health Campaign, a national initiative to promote mental fitness and work towards reducing suicide rates in Australia.
-
GLP-1RAs link with eye conditions confirmed
Tuesday | Aug 12 2025TWO large studies published today have confirmed links between GLP-1RAs, the group of diabetes and weight loss drugs that includes Ozempic, and eye conditions.
